What Does CAPA Stand For in Clinical Trial Research?

CAPA stands for Corrective and Preventive Action. In clinical research it names the formal process an organisation uses to resolve a quality event: fix what went wrong, establish why it happened, and change the conditions that allowed it.

The acronym appears across regulated industries. Pharmaceutical manufacturing, medical devices and clinical research all run CAPA processes, and the letters mean the same thing in each. What changes is the evidence the process has to produce and the inspectorate that asks for it.

What CAPA Means in Clinical Research

A clinical trial generates quality events continuously. A consent form signed after the first procedure. A delegation log entry added weeks after the activity. An investigational product stored outside its approved range over a bank holiday. Each one is recorded, and each one raises the same question from a sponsor or an inspector: what did you do about it, and how do you know it worked?

CAPA is the answer to that question in a form that survives scrutiny. The record carries what happened, what caused it, what changed as a result, who was accountable at each step, and the evidence that the change held. Regulators expect research organisations to maintain control rather than avoid every error. A functioning CAPA process is how control is demonstrated.

Corrective Action and Preventive Action: The Difference

The two halves of the acronym do different work, and confusing them is the most common weakness in a CAPA record.

Corrective Action

Corrective action addresses the event that already occurred. A consent form was signed late, so the participant’s eligibility is reconfirmed, the deviation is reported to the sponsor and the ethics committee, and the record is corrected with an explanation of the sequence.

Corrective action is bounded. It closes the specific gap in front of you and nothing further.

Preventive Action

Preventive action addresses the conditions that made the event possible. The consent process was ambiguous about sequencing, so the SOP is rewritten, the site team is retrained against the revised version, and the study visit workflow blocks the first procedure until consent is recorded.

Preventive action is structural. It changes what the next person encounters.

A CAPA record carries both. Corrective action alone repairs the instance and leaves the cause in place, which is why the same finding reappears at the next monitoring visit. Preventive action alone changes the system while the original event sits unresolved.

Related Terms You Will See

CAPA plan. The documented set of actions raised against one quality event, with owners, due dates and verification criteria.

Root cause. The structural reason the event occurred, established by investigation. A root cause statement describes a condition in the system rather than a person’s mistake.

Effectiveness verification. The check performed after the actions are complete, confirming the event has stopped recurring under real operating conditions.

Quality event. The umbrella term for anything that can raise a CAPA: a protocol deviation, an audit finding, a document non-conformance, an inspection observation, a risk signal from monitoring.

Why the Distinction Matters at Inspection

MHRA inspectors review CAPA records during sponsor and site inspections, and the review follows a predictable line. They select a finding, follow it to its CAPA, read the root cause statement, and ask whether the actions taken could plausibly have addressed that cause.

A record where every action is corrective fails that test quickly. Retraining one coordinator after a documentation error addresses the coordinator. It leaves the SOP, the workflow and the oversight step exactly as they were. The finding recurs, and a repeated finding with a closed CAPA behind it reads as a quality system that records problems without resolving them.

ICH-GCP E6(R3) sets expectations around quality issue management and effectiveness evaluation. Those expectations are met through the preventive half of the process and the verification that follows it.

Where CAPA Sits in the Quality System

CAPA operates inside the quality management system, and it depends on the records that system holds. A preventive action that revises an SOP needs controlled document management to make the revision the operative version. A preventive action that adds a training requirement needs the training record to show completion. A CAPA raised against a delegated activity needs the delegation of authority log to establish who was authorised at the time.

Those connections are where CAPA processes break in practice. The actions are sound and the follow-through depends on somebody manually reconciling three separate systems.

Going Further

This page covers the acronym and the distinction behind it. For the full process, the seven stages of the lifecycle, what regulators ask during inspection, and how CAPA management software enforces the sequence, read the complete guide to CAPA management in clinical research.

To see the reasoning applied to one real finding from detection through to verified closure, work through a CAPA example of a clinical trial deviation.

Guide
By Ash Mahmud· · · Book a 30 min demo
In this guide
AM
Written by
Ash Mahmud
Co-founder, AQ Trials

Ash has spent over twenty years inside clinical research operations and technology, working alongside NHS Trusts, CROs, sponsors, and academic research organisations. He co-founded AQ Trials to give research teams one connected, inspection-ready operational record.

See the connected platform behind this guide

A 30-minute walkthrough built around your operational priorities — study execution, documentation, quality and pharmacy in one governed record.

Book a 30 min demo →
See the AQ Platform in action — a 30-minute walkthrough for teams like yoursBook a 30 min demo →
Free guides · PDF
Find the right guide for you

Pick a module, your organisation type, or both — we'll match the guides and email them to you.

Most popular guides
Explore
15+ guides

Free guides · PDF

Guides matched to you.

Written for first-in-human & Phase 1 sites

Inspection-ready checklists & templates

Aligned to MHRA, FDA & EU Annex 11